Literature DB >> 32061879

Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.

Peng Liu1, Shuo Chen2, Zhuo-Ying Wu2, Meng Qi2, Xiang-Yang Li3, Cai-Xia Liu4.   

Abstract

OBJECTIVES: Older antimicrobials such as fosfomycin are being considered as alternative agents in the treatment of drug-resistant organisms. However, there are limited data on the usefulness of fosfomycin against carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prevalence of fosfomycin resistance and associated mechanisms in CRKP.
METHODS: A total of 99 clinical CRKP isolates were collected in the Second Affiliated Hospital of Wenzhou Medical University (Wenzhou, China) between January 2017 and June 2018. Fosfomycin susceptibility testing was performed by the agar dilution method. Carbapenemase and fosfomycin resistance genes were detected by PCR. Analysis of the murA, glpT, uhpT, uhpA, ptsI and cyaA genes was performed by PCR and sequencing of four fosfomycin-resistant fosA3-negative CRKP strains. Conjugation experiments were employed to determine the mobility of the fosA3 gene.
RESULTS: Of the 99 CRKP isolates, fosfomycin-non-susceptibility was detected in 48 (48.5%) isolates, among which the fosA3 gene was detected in 44. Among the four fosfomycin-resistant fosA3-negative CRKP isolates, one isolate possessed a single nucleotide insertion and deletion mutations as well as 219 nucleotide substitution mutations in murA, two isolates possessed deletion or mutation of large DNA fragments in glpT, and one isolate possessed a fragment insertion sequence in glpT. Transfection into Escherichia coli J53 via plasmid conjugation was successful for 19 (43.2%) of the 44 fosA3-positive CRKP isolates.
CONCLUSION: The fosA3 gene is the primary mechanism of fosfomycin resistance in CRKP and can be transmitted widely by plasmid in hospitals. Mutations in murA and glpT were found in fosfomycin-resistant fosA3-negative CRKP.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Carbapenems; Fosfomycin resistance; Klebsiella pneumoniae; fosA3

Mesh:

Substances:

Year:  2020        PMID: 32061879     DOI: 10.1016/j.jgar.2019.12.019

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  6 in total

1.  Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China.

Authors:  Haichen Wang; Changhang Min; Jun Li; Ting Yu; Yongmei Hu; Qingya Dou; Mingxiang Zou
Journal:  BMC Microbiol       Date:  2021-04-11       Impact factor: 3.605

2.  Clonal Dissemination of Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates Carrying fosA3 and bla KPC-2 Coharboring Plasmids in Shandong, China.

Authors:  Yingying Hao; Xuguang Zhao; Cui Zhang; Yuanyuan Bai; Zhen Song; Xinglun Lu; Ran Chen; Yaoyao Zhu; Yueling Wang
Journal:  Front Microbiol       Date:  2021-12-17       Impact factor: 5.640

3.  Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Yu-Ping Wang; Yen-Hao Chen; I-Cheng Hung; Po-Hsun Chu; Yu-Han Chang; Yi-Tsung Lin; Hung-Chih Yang; Jin-Town Wang
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

4.  Fosfomycin resistance in community-acquired urinary pathogens from Western Cape, South Africa.

Authors:  Lesedi B Mosime; Mae Newton-Foot; Pieter Nel
Journal:  S Afr J Infect Dis       Date:  2022-01-19

Review 5.  Advances in UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Covalent Inhibition.

Authors:  Maycon Vinicius Damasceno de Oliveira; Renan Machado Furtado; Kauê S da Costa; Serhii Vakal; Anderson H Lima
Journal:  Front Mol Biosci       Date:  2022-07-20

6.  Emergence of Multidrug-Resistant Escherichia coli Producing CTX-M, MCR-1, and FosA in Retail Food From Egypt.

Authors:  Hazem Ramadan; Ahmed M Soliman; Lari M Hiott; Mohammed Elbediwi; Tiffanie A Woodley; Marie A Chattaway; Claire Jenkins; Jonathan G Frye; Charlene R Jackson
Journal:  Front Cell Infect Microbiol       Date:  2021-07-13       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.